Clinical Trial Update: Study Evaluating the Long-Term Safety and Efficacy of ABX464 in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the long-term safety and efficacy of ABX464 in patients with moderate-to-severe rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ABX464 (ABX464)

Snippet

Sponsor: Abivax S.A. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED